BKGI fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Bangkok Genomics Innovation PCL engages in the provision of screening services for fetal chromosomal abnormalities. It offers screening for genetic abnormalities, analysis infectious disease group, cancer related screening, genetic code analysis with whole exome sequencing, individual genetic testing, newborn screening, basic health check-up, providing technology services and other medical products. The company was founded in 2017 and is headquartered in Bangkok, Thailand.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
BKGI does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company